LIPOCINE INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-03-31 was 4.58K shares.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-12-31 was 0.00 shares.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-06-30 was 0.00 shares.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 0.00 shares, a 100.00% decline from fiscal 2019.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 20.00K shares.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 0.00 shares.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2014 was 20.20K shares, a 437.22% increase from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2021-03-31 | 4.58K shares 10-Q · filed 2021-05-06 | 4.58K shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 0.00 shares 10-K · filed 2021-03-11 |
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-10 | 0.00 shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-08-06 | 20.00K shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-06 | 20.00K shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 20.00K shares 10-K · filed 2021-03-11 |
| 2019-09-30 | 20.00K shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 0.00 shares 10-Q · filed 2020-08-06 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | 0.00 shares 10-K · filed 2020-03-13 |
| 2018-09-30 | 0.00 shares 10-Q · filed 2019-11-12 | |
| 2018-06-30 | 0.00 shares 10-Q · filed 2019-08-07 | |
| 2015-09-30 | 42.72K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 98.57K shares derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-06-30 | 7.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | 55.86K shares derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-03-31 | 48.71K shares 10-Q · filed 2015-05-07 | 68.91K shares derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | 20.20K shares 10-K · filed 2015-03-11 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 20.20K shares derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | 20.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-13 | |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | 3.76K shares 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |